[Macular hole surgery with and without internal limiting membrane peeling]
- PMID: 12677493
[Macular hole surgery with and without internal limiting membrane peeling]
Abstract
Purpose: To determine if internal limiting membrane (ILM) peeling in idiopathic macular hole surgery improves anatomic and functional results.
Methods: Comparative retrospective, nonrandomized study, of 50 eyes from 48 patients with macular hole, Stage III an IV of the Gass Classification. All of them were operated with the same technique. In 25 eyes the ILM was peeled (group 1). In the other 25 eyes the ILM was not peeled (group 2). We compare the anatomic and functional outcome as well as the complications in both groups.
Results: The overall anatomic success rate in the 50 eyes was 92% (46 eyes). In group 1 the anatomic success rate was 100% and 84% in group 2 (p=0.018). The visual acuity improved, one or more Snellen lines, in 34 of the 50 operated eyes (68%). In group 1 the visual acuity improved in 20 of the 25 eyes (80%) and in group 2 in 14 of the 25 eyes (56%) (p=0.034). The most relevant complications included retinal detachment, two cases in group 1 and one case in group 2, cataract and retinal pigment epithelium changes.
Conclusions: In our experience, internal limiting membrane peeling in macular hole surgery improves the anatomic and functional success, but not the final visual acuity.
Similar articles
-
Results of macular hole surgery with and without epiretinal dissection or internal limiting membrane removal.Ophthalmology. 2004 Jan;111(1):142-9. doi: 10.1016/j.ophtha.2003.05.005. Ophthalmology. 2004. PMID: 14711726
-
Outcome results in macular hole surgery: an evaluation of internal limiting membrane peeling with and without indocyanine green.Ophthalmology. 2003 Sep;110(9):1697-701. doi: 10.1016/S0161-6420(03)00562-1. Ophthalmology. 2003. PMID: 13129864
-
Long-term follow-up of indocyanine green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for idiopathic macular hole repair.Ophthalmology. 2004 Dec;111(12):2246-53. doi: 10.1016/j.ophtha.2004.05.037. Ophthalmology. 2004. PMID: 15582081
-
[Surgery for retinal internal limiting membrane (communication 2)].Vestn Oftalmol. 2009 Nov-Dec;125(6):51-5. Vestn Oftalmol. 2009. PMID: 20143544 Review. Russian.
-
[Surgery for retinal internal limiting membrane (communication 1)].Vestn Oftalmol. 2009 Nov-Dec;125(6):46-51. Vestn Oftalmol. 2009. PMID: 20143543 Review. Russian.
Cited by
-
Enzymatic vitreolysis with recombinant tissue plasminogen activator for vitreomacular traction.Drug Des Devel Ther. 2015 Nov 27;9:6259-68. doi: 10.2147/DDDT.S88361. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26664047 Free PMC article.